MAK-SYSTEM, founded in 1984, is a worldwide leader in Blood Management systems, supplying innovative, end-to-end digital solutions to optimize the collection, storage, and distribution of blood, plasma, tissue, and biologics for cell & gene therapies.
Their comprehensive software portfolio is modular and includes core products like eProgesa (Blood Establishment Computer System and Plasma Management), eTraceLine (Transfusion Management System), Cosmas/TCS (Cell and Tissue Therapy Orchestration Platform), and eDRM (Donor Relationship Management). The platform is designed to digitalize and automate the entire value chain, ensuring full traceability, efficiency, and safety for products of human origin.
MAK-SYSTEM's solutions are utilized by Blood Centers, Plasma Centers, Transfusion Services, Tissue Banks, and Cell & Gene Therapy Centers in over 35 countries, managing nearly 1 in 3 blood donations globally.
MAK.care, launched in 2022, is the company's global cloud platform for blood and biological products delivered as a managed service in partnership with AWS. This managed service model includes 24/7 global support, cybersecurity, encryption, backups, and disaster recovery, allowing clients to focus on their core business.
Key Capabilities:
- End-to-end automation and traceability of blood, plasma, tissue, and cell products.
- Donor recruitment, communication, and management (eDRM).
- Integrated hospital transfusion management and laboratory services (eTraceLine).
- Patient-centric platform for tissue, cell, and gene therapy supply chain orchestration (Cosmas).
- Compliance with global regulatory standards (FDA, AABB, ISBT 128, etc.).
